Digital biomarkers are playing a significant role in reshaping the concepts as well as an understanding of disease and health, an aspect that had had a substantial impact on the manner in which individual relationships to an environment is determined, how treatment efficiency is determined, and how research studies are conducted.

CRU-GLOBAL via its international clinical and academic research network is dedicated to develop and use disrupted technologies in the field of preclinical and clinical research to be able to implement as soon as possible the advantages provided these technologies into the everyday practice.

CRU-GLOBAL gets all the scientific, clinical and real world data access inhouse or with excellent academic partners to achieve this goal quickly.